Non-alcoholic fatty pancreas disease – practices for clinicians
Obesity is a growing health burden worldwide, increasing the risk for several diseases featuring the metabolic syndrome – type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease and cardiovascular diseases. With the increasing epidemic of obesity, a new pathologic condition has eme...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2019-09-01
|
| Series: | Romanian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjim-2019-0005 |
| _version_ | 1811290185758932992 |
|---|---|
| author | Pinte Larisa Balaban Daniel Vasile Băicuş Cristian Jinga Mariana |
| author_facet | Pinte Larisa Balaban Daniel Vasile Băicuş Cristian Jinga Mariana |
| author_sort | Pinte Larisa |
| collection | DOAJ |
| description | Obesity is a growing health burden worldwide, increasing the risk for several diseases featuring the metabolic syndrome – type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease and cardiovascular diseases. With the increasing epidemic of obesity, a new pathologic condition has emerged as a component of the metabolic syndrome – that of non-alcoholic fatty pancreas disease (NAFPD). Similar to non-alcoholic fatty liver disease (NAFLD), NAFPD comprises a wide spectrum of disease – from deposition of fat in the pancreas – fatty pancreas, to pancreatic inflammation and possibly pancreatic fibrosis. In contrast with NAFLD, diagnostic evaluation of NAFPD is less standardized, consisting mostly in imaging methods. Also the natural evolution of NAFPD and its association with pancreatic cancer is much less studied. Not least, the clinical consequences of NAFPD remain largely presumptions and knowledge about its metabolic impact is limited. This review will cover epidemiology, pathogenesis, diagnostic evaluation tools and treatment options for NAFPD, with focus on practices for clinicians. |
| first_indexed | 2024-04-13T04:08:31Z |
| format | Article |
| id | doaj.art-15ce053dd6ed43598b21ba9ed1e9d0ae |
| institution | Directory Open Access Journal |
| issn | 2501-062X |
| language | English |
| last_indexed | 2024-04-13T04:08:31Z |
| publishDate | 2019-09-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Romanian Journal of Internal Medicine |
| spelling | doaj.art-15ce053dd6ed43598b21ba9ed1e9d0ae2022-12-22T03:03:10ZengSciendoRomanian Journal of Internal Medicine2501-062X2019-09-0157320921910.2478/rjim-2019-0005rjim-2019-0005Non-alcoholic fatty pancreas disease – practices for cliniciansPinte Larisa0Balaban Daniel Vasile1Băicuş Cristian2Jinga Mariana3“Colentina” Clinical Hospital, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania“Colentina” Clinical Hospital, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaObesity is a growing health burden worldwide, increasing the risk for several diseases featuring the metabolic syndrome – type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease and cardiovascular diseases. With the increasing epidemic of obesity, a new pathologic condition has emerged as a component of the metabolic syndrome – that of non-alcoholic fatty pancreas disease (NAFPD). Similar to non-alcoholic fatty liver disease (NAFLD), NAFPD comprises a wide spectrum of disease – from deposition of fat in the pancreas – fatty pancreas, to pancreatic inflammation and possibly pancreatic fibrosis. In contrast with NAFLD, diagnostic evaluation of NAFPD is less standardized, consisting mostly in imaging methods. Also the natural evolution of NAFPD and its association with pancreatic cancer is much less studied. Not least, the clinical consequences of NAFPD remain largely presumptions and knowledge about its metabolic impact is limited. This review will cover epidemiology, pathogenesis, diagnostic evaluation tools and treatment options for NAFPD, with focus on practices for clinicians.https://doi.org/10.2478/rjim-2019-0005non-alcoholic fatty pancreasmetabolic syndromediabetes mellitus |
| spellingShingle | Pinte Larisa Balaban Daniel Vasile Băicuş Cristian Jinga Mariana Non-alcoholic fatty pancreas disease – practices for clinicians Romanian Journal of Internal Medicine non-alcoholic fatty pancreas metabolic syndrome diabetes mellitus |
| title | Non-alcoholic fatty pancreas disease – practices for clinicians |
| title_full | Non-alcoholic fatty pancreas disease – practices for clinicians |
| title_fullStr | Non-alcoholic fatty pancreas disease – practices for clinicians |
| title_full_unstemmed | Non-alcoholic fatty pancreas disease – practices for clinicians |
| title_short | Non-alcoholic fatty pancreas disease – practices for clinicians |
| title_sort | non alcoholic fatty pancreas disease practices for clinicians |
| topic | non-alcoholic fatty pancreas metabolic syndrome diabetes mellitus |
| url | https://doi.org/10.2478/rjim-2019-0005 |
| work_keys_str_mv | AT pintelarisa nonalcoholicfattypancreasdiseasepracticesforclinicians AT balabandanielvasile nonalcoholicfattypancreasdiseasepracticesforclinicians AT baicuscristian nonalcoholicfattypancreasdiseasepracticesforclinicians AT jingamariana nonalcoholicfattypancreasdiseasepracticesforclinicians |